| Literature DB >> 36201372 |
Jennifer P Collins, Hazel J Shah, Daniel Lowell Weller, Logan C Ray, Kirk Smith, Suzanne McGuire, Rosalie T Trevejo, Rachel H Jervis, Duc J Vugia, Tamara Rissman, Katie N Garman, Sarah Lathrop, Bethany LaClair, Michelle M Boyle, Stic Harris, Joanna Zablotsky Kufel, Robert V Tauxe, Beau B Bruce, Erica Billig Rose, Patricia M Griffin, Daniel C Payne.
Abstract
To evaluate progress toward prevention of enteric infections in the United States, the Foodborne Diseases Active Surveillance Network (FoodNet) conducts active population-based surveillance for laboratory-diagnosed infections caused by Campylobacter, Cyclospora, Listeria, Salmonella, Shiga toxin-producing Escherichia coli (STEC), Shigella, Vibrio, and Yersinia at 10 U.S. sites. This report summarizes preliminary 2021 data and describes changes in annual incidence compared with the average annual incidence for 2016-2018, the reference period for the U.S. Department of Health and Human Services' (HHS) Healthy People 2030 goals for some pathogens (1). During 2021, the incidence of infections caused by Salmonella decreased, incidence of infections caused by Cyclospora, Yersinia, and Vibrio increased, and incidence of infections caused by other pathogens did not change. As in 2020, behavioral modifications and public health interventions implemented to control the COVID-19 pandemic might have decreased transmission of enteric infections (2). Other factors (e.g., increased use of telemedicine and continued increase in use of culture-independent diagnostic tests [CIDTs]) might have altered their detection or reporting (2). Much work remains to achieve HHS Healthy People 2030 goals, particularly for Salmonella infections, which are frequently attributed to poultry products and produce, and Campylobacter infections, which are frequently attributed to chicken products (3).Entities:
Mesh:
Year: 2022 PMID: 36201372 PMCID: PMC9541031 DOI: 10.15585/mmwr.mm7140a2
Source DB: PubMed Journal: MMWR Morb Mortal Wkly Rep ISSN: 0149-2195 Impact factor: 35.301
Number of laboratory-diagnosed bacterial and parasitic infections, hospitalizations, deaths, outbreak-associated infections, crude incidence, and percentage change compared with 2016–2018 average annual incidence, by pathogen — Foodborne Diseases Active Surveillance Network, 10 U.S. sites,* 2021
| Pathogen | 2021 | % Change in infection incidence (95% CrI¶¶), 2016–2018 to 2021 | ||||
|---|---|---|---|---|---|---|
| No. of Infections§ | No. (%) | Crude incidence§§ | ||||
| Hospitalizations¶ | Deaths** | Outbreak-associated infections†† | ||||
|
|
|
|
|
|
|
|
|
| ||||||
|
| 8,974 | 1,822 (20) | 33 (0.4) | 51 (0.6) | 17.8 | −5.5 (−11.4 to 0.9) |
|
| 7,148 | 1,974 (28) | 52 (0.7) | 597 (8) | 14.2 | −10.0 (−16.9 to −3.2) |
| STEC*** | 2,542 | 600 (24) | 10 (0.4) | 79 (3) | 5.0 | 8.8 (−6.8 to 27.0) |
|
| 1,699 | 532 (31) | 8 (0.5) | 67 (4) | 3.4 | −14.8 (−33.8 to 6.0) |
|
| 683 | 146 (21) | 3 (0.4) | 2 (0.3) | 1.4 | 79.0 (49.4 to 116.1) |
|
| 461 | 117 (25) | 9 (2) | 8 (2) | 0.9 | 45.5 (26.9 to 66.3) |
|
| 148 | 140 (95) | 37 (25) | 9 (6) | 0.3 | 4.6 (−8.5 to 20.1) |
|
| ||||||
|
| 364 | 28 (8) | 1 (0.3) | 48 (13) | 0.7 | 443.2 (195.9 to 1,134.2) |
Abbreviations: CIDT = culture-independent diagnostic test; CrI = credible interval; STEC = Shiga toxin–producing Escherichia coli.
* Data were obtained from laboratories in Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York.
† 2021 data are preliminary.
§ Bacterial infections diagnosed by culture or CIDT. Cyclospora infections diagnosed by microcopy or polymerase chain reaction.
¶ Admission to an inpatient unit or an observation stay of >24 hours within 7 days before or after specimen collection or determined to be related to the infection if beyond this time frame. Absolute change in percentage of infections resulting in hospitalization during 2021 compared with annual average for 2016–2018: Campylobacter (0.3), Salmonella (0.3), STEC (1), Shigella (8), Yersinia (−4), Vibrio (−5), Listeria (−2), Cyclospora (2), and overall (0.6). Unknown hospitalization status (10% of infections during 2021 and 4% during 2016–2018) was classified as not hospitalized.
** Attributed to infection when deaths occurred during hospitalization or within 7 days after specimen collection for nonhospitalized patients. Absolute change in percentage of infections resulting in death during 2021 compared with annual average for 2016–2018: Campylobacter (<0.1), Salmonella (0.3), STEC (<0.1), Shigella (0.4), Yersinia (−0.7), Vibrio (−0.2), Listeria (6), Cyclospora (0.1), and overall (0.2). Unknown death status (8% of infections during 2021 and 3% during 2016–2018) was not classified as a death.
†† Generally defined as two or more cases of similar illness associated with a common exposure; some sites also stipulate that illnesses be from more than one household. Absolute change in percentage of outbreak-associated infections during 2021 compared with annual average for 2016–2018: Campylobacter (0.2) Salmonella (1), STEC (−1), Shigella (−1), Yersinia (0.2), Vibrio (−2), Listeria (1), Cyclospora (−10), and overall (<0.1). Unknown outbreak-association status (0.02% of infections during 2021 and 0% during 2016–2018) was classified as not outbreak-associated.
§§ Cases per 100,000 population. Domestic incidences (cases with no or unknown travel) by pathogen during 2021: Campylobacter (17.0), Salmonella (13.1), STEC (4.6), Shigella (3.0), Yersinia (1.3), Vibrio (0.8), Listeria (0.3), and Cyclospora (0.6).
¶¶ Percentage change reported as increase or decrease. Some increases are likely due to increasing use of CIDTs by clinical laboratories.
*** Compared with the annual average for 2016–2018, the incidence of STEC O157 infections (0.6 per 100,000) changed by −21.7% (95% CrI = −32.4% to −11.5%), and the incidence of non-O157 STEC infections (1.8) changed by −11.6% (95% CrI = −26.2% to 7.0%).
FIGURENumber of laboratory-diagnosed bacterial and parasitic infections and percentage of persons with international travel,* by month — Foodborne Diseases Active Surveillance Network, 10 U.S. sites, 2016–2018 and 2021
* History of international travel before illness began: 30 days for Listeria and Salmonella serotypes Typhi and Paratyphi, 14 days for Cyclospora, and 7 days for other pathogens. Unknown international travel (25% of infections during 2021 and 17% during 2016–2018) was classified as no travel.
† Data were obtained from laboratories in Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York.
§ 2021 data are preliminary.
Percentage of bacterial infections diagnosed by a culture-independent diagnostic test, only by a culture-independent diagnostic test, with a reflex culture, and percentage of reflex cultures that yielded a pathogen — Foodborne Diseases Active Surveillance Network, 10 U.S. sites,* 2016–2018 and 2021
| Pathogen | Infections diagnosed by CIDT, %§ | Infections diagnosed only by CIDT, %¶ | Infections with a reflex culture, %** | Reflex culture yielded a pathogen, %†† | |||||
|---|---|---|---|---|---|---|---|---|---|
| 2016–2018 | 2021 | 2016–2018 | 2021 | 2016–2018 | 2021 | 2016–2018 | 2021 | ||
|
|
|
|
|
|
|
|
|
| |
|
| 53 | 70 | 36 | 46 | 60 | 56 | 55 | 62 | |
|
| 4 | 13 | 0 | 2 | 100 | 95 | 88 | 89 | |
|
| 30 | 49 | 9 | 15 | 79 | 85 | 88 | 83 | |
|
| 49 | 76 | 29 | 44 | 69 | 83 | 58 | 51 | |
| STEC | 100 | 100 | 43 | 53 | 88 | 80 | 65 | 59 | |
|
| 45 | 61 | 31 | 46 | 83 | 73 | 38 | 33 | |
|
| 69 | 85 | 46 | 71 | 69 | 68 | 48 | 24 | |
Abbreviations: CIDT = culture-independent diagnostic test; STEC = Shiga toxin–producing Escherichia coli.
* Data were obtained from laboratories in Connecticut, Georgia, Maryland, Minnesota, New Mexico, Oregon, Tennessee, and selected counties in California, Colorado, and New York.
† 2021 data are preliminary.
§ Includes specimens that had a culture performed, regardless of the result, and those not cultured. Denominator is total infections.
¶ Includes specimens that had a negative culture result and those not cultured. Denominator is total infections.
** Specimens with a positive CIDT result that had a culture performed, regardless of the result. Denominator is infections diagnosed by CIDT.
†† Denominator is specimens with a reflex culture.